Sign inJoin waitlistJoin the waitlist

SC

Sant Chawla

Physician · Sant P. Chawla M.d. Inc.

Credentials: · · · · ·

History

Sant P. Chawla M.d. Inc.
Present

Medical Oncology
1978–1980
Internal Medicine
1975–1978
ALL INDIA INST OF MED SCI, ANSARI NAGAR, NEW DELHI, DELHI
1971–1975

Research

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
The Lancet · 2012 · 1,690 citations
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
The Lancet Oncology · 2020 · 1,363 citations
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in…
Journal of Clinical Oncology · 2003 · 593 citations

EG
Erlinda Gordon
19 papers
George Demetri
16 papers
RB
Robert Benjamin
16 papers
Steven Attia
16 papers
RM
Robert Maki
14 papers
SS
Scott Schuetze
14 papers
BT
Brian Van Tine
13 papers
Vivek Subbiah
13 papers
Kristen Ganjoo
12 papers
Richard Riedel
12 papers
RJ
Robin Jones
12 papers
Scott Okuno
12 papers

Clinical trials

A Phase 2 Study Using Aliya PEF Plus Pembro for Sarcoma
Principal investigator · Withdrawn · Phase 2
Sarcoma Oncology Research Center, LLC
2024–2025
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
Principal investigator · Recruiting · Phase 2
Sarcoma Oncology Research Center, LLC
2021–2029
GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma
Principal investigator · Unknown · Phase 2
Sarcoma Oncology Research Center, LLC
2020–2025
SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma
Principal investigator · Active not recruiting · Phase 2
Sarcoma Oncology Research Center, LLC
2020–2028